Literature DB >> 15750689

Identification of CBFA1-regulated genes on SaOs-2 cells.

Karine Bertaux1, Odile Broux, Christophe Chauveau, Joseph Jeanfils, Jean-Christophe Devedjian.   

Abstract

Current knowledge about mechanisms controlling osteoblast-specific gene expression has led to the identification of Cbfa1 as a key regulator of osteoblast differentiation. Several essential questions about this transcription factor remain to be addressed, e.g., the nature of stimuli that may modulate its own expression, as well as the genetic repercussions following alterations in Cbfa1 levels. To identify such Cbfa1-responsive genes, the SaOs-2 cell line was stably transfected with a dominant negative mutant of Cbfa1 (DeltaCbfa1). Comparison of gene expression patterns by differential display on selected SaOs-2 clones allowed the identification of four new genes that may be under the control of Cbfa1. Three of them, SelM, elF-4AI, and RPS24, seemed to be linked to a global change in cellular metabolism and cell growth. The fourth, the CD99/MIC2 gene, was strongly overexpressed (around tenfold) in cells presenting high levels of Deltacbfa1. This observation adds evidence to show that this marker of Ewing family tumors is linked to the osteoblast lineage. The exact function of CD99 remains largely undefined, and this is the first time that its regulation by an essential transcription factor involved in osteoblast differentiation has been observed.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15750689     DOI: 10.1007/s00774-004-0549-4

Source DB:  PubMed          Journal:  J Bone Miner Metab        ISSN: 0914-8779            Impact factor:   2.626


  6 in total

1.  CD99 acts as an oncosuppressor in osteosarcoma.

Authors:  Maria Cristina Manara; Ghislaine Bernard; Pier-Luigi Lollini; Patrizia Nanni; Monia Zuntini; Lorena Landuzzi; Stefania Benini; Giovanna Lattanzi; Marika Sciandra; Massimo Serra; Mario Paolo Colombo; Alain Bernard; Piero Picci; Katia Scotlandi
Journal:  Mol Biol Cell       Date:  2006-01-18       Impact factor: 4.138

2.  The post-translational phenotype of collagen synthesized by SAOS-2 osteosarcoma cells.

Authors:  Russell J Fernandes; Michael A Harkey; Maryann Weis; Jennifer W Askew; David R Eyre
Journal:  Bone       Date:  2007-01-25       Impact factor: 4.398

3.  Human myeloma cell lines induce osteoblast downregulation of CD99 which is involved in osteoblast formation and activity.

Authors:  Angela Oranger; Giacomina Brunetti; Claudia Carbone; Graziana Colaianni; Teresa Mongelli; Isabella Gigante; Roberto Tamma; Giorgio Mori; Adriana Di Benedetto; Marika Sciandra; Selena Ventura; Katia Scotlandi; Silvia Colucci; Maria Grano
Journal:  J Immunol Res       Date:  2015-04-27       Impact factor: 4.818

4.  CD99 drives terminal differentiation of osteosarcoma cells by acting as a spatial regulator of ERK 1/2.

Authors:  Marika Sciandra; Maria Teresa Marino; Maria Cristina Manara; Clara Guerzoni; Maria Grano; Angela Oranger; Enrico Lucarelli; Pier-Luigi Lollini; Barbara Dozza; Loredana Pratelli; Maria Flavia Di Renzo; Mario Paolo Colombo; Piero Picci; Katia Scotlandi
Journal:  J Bone Miner Res       Date:  2014       Impact factor: 6.741

5.  CD99/MIC2 Constitutes a Differentiation Antigen of a Human Osteoblast Cell Line.

Authors:  Gerhard Hamilton; Ulrike Olszewski-Hamilton
Journal:  World J Oncol       Date:  2011-12-19

Review 6.  CD99 at the crossroads of physiology and pathology.

Authors:  Michela Pasello; Maria Cristina Manara; Katia Scotlandi
Journal:  J Cell Commun Signal       Date:  2018-01-06       Impact factor: 5.782

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.